Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.23
Delayed Data
As of Jul 06
 +0.07 / +6.03%
Today’s Change
0.80
Today|||52-Week Range
3.66
-30.40%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Scopa James Paul
Director
Sale11/15/202150,000$2.18$109.0K-43.32%
Soparkar Peter
N/A
Buy12/08/202125,000$1.91$47.8K-34.22%
Fischer Laurent
Buy4/20/202225,000$1.11$27.8K+7.89%
Fischer Laurent
Buy12/09/202114,323$1.85$26.5K-33.15%
Svoronos Dawn A
Director
Buy5/16/202230,000$0.85$25.5K+51.91%
Soparkar Peter
N/A
Buy4/19/202221,750$1.14$24.8K+9.82%
Fischer Laurent
Buy12/08/202110,677$1.79$19.1K-34.22%
Seyedkazemi Star
Chief Development Officer
Buy5/23/202220,000$0.84$16.8K+48.91%
Clark Julie /adverum/
Chief Medical Officer
Sale9/30/20214,766$2.17$10.3K-43.32%
Dsouza Rupert
Chief Financial Officer
Buy5/13/202210,000$0.86$8.6K+47.22%
Page of 2